Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Planned sale Chief Legal Officer sold 14,261 shares at $16.66 ($237,618)
  3. 4 Exercise or conversion Chief Scientific Officer acquired 31,333 shares (option exercise)
  4. 4 Open-market sale Chief Financial Officer sold 3,661 shares at an average $16.60 ($60,767)
  5. 4 Open-market sale Chief Legal Officer sold 4,421 shares at an average $16.60 ($73,381)
  6. 4 Open-market sale Chief Scientific Officer sold 4,895 shares at an average $16.60 ($81,249)
  7. 4 Planned sale Chief Legal Officer sold 3,760 shares at $18.42 ($69,273)
  8. 4 Planned sale Chief Legal Officer sold 3,760 shares at an average $17.90 ($67,314)
  9. 4 Planned sale Chief Legal Officer sold 37,600 shares at $17.07 ($641,697)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Chief Financial Officer sold 6,284 shares at $12.56 ($78,931)
  13. 4 Open-market sale Chief Financial Officer sold 3,130 shares at $12.80 ($40,054)
  14. 4 Open-market sale Chief Legal Officer sold 3,644 shares at $12.80 ($46,631)
  15. 4 Open-market sale Chief Scientific Officer sold 4,087 shares at $12.80 ($52,300)
  16. 4 Derivatives Options or other derivatives
  17. 4 Exercise or conversion Director acquired 10,750 shares (option exercise)
  18. 4 Planned sale Chief Financial Officer sold 5,402 shares at $11.03 ($59,598)
  19. 4 Open-market sale Chief Financial Officer sold 4,304 shares at $12.01 ($51,695)
  20. 4 Open-market sale Chief Legal Officer sold 3,841 shares at $12.01 ($46,134)

Page 3 of 14 · 274 filings